|
US2961377A
(en)
|
1957-08-05 |
1960-11-22 |
Us Vitamin Pharm Corp |
Oral anti-diabetic compositions and methods
|
|
US3960949A
(en)
|
1971-04-02 |
1976-06-01 |
Schering Aktiengesellschaft |
1,2-Biguanides
|
|
US4494978A
(en)
|
1976-12-30 |
1985-01-22 |
Chevron Research Company |
Herbicidal N-(N'-hydrocarbyloxycarbamylalkyl)-2,6-dialkyl-alpha-haloacetanilides
|
|
AU592765B2
(en)
*
|
1984-08-15 |
1990-01-25 |
Schering Aktiengesellschaft |
New dopamine derivatives, process for their production, and their use as medicinal products
|
|
US4935493A
(en)
|
1987-10-06 |
1990-06-19 |
E. I. Du Pont De Nemours And Company |
Protease inhibitors
|
|
US5433955A
(en)
|
1989-01-23 |
1995-07-18 |
Akzo N.V. |
Site specific in vivo activation of therapeutic drugs
|
|
US5366862A
(en)
|
1990-02-14 |
1994-11-22 |
Receptor Laboratories, Inc. |
Method for generating and screening useful peptides
|
|
US5814460A
(en)
|
1990-02-14 |
1998-09-29 |
Diatide, Inc. |
Method for generating and screening useful peptides
|
|
US5462928A
(en)
|
1990-04-14 |
1995-10-31 |
New England Medical Center Hospitals, Inc. |
Inhibitors of dipeptidyl-aminopeptidase type IV
|
|
DE4110019C2
(de)
|
1991-03-27 |
2000-04-13 |
Merck Patent Gmbh |
Imidazopyridine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
|
|
US5387512A
(en)
|
1991-06-07 |
1995-02-07 |
Merck & Co. Inc. |
Preparation of 3-[z-benzoxazol-2-yl)ethyl]-5-(1-hydroxyethyl)-6-methyl-2-(1H)-pyridinone by biotransformation
|
|
US5268376A
(en)
|
1991-09-04 |
1993-12-07 |
Minnesota Mining And Manufacturing Company |
1-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
|
ATE199016T1
(de)
|
1991-10-22 |
2001-02-15 |
New England Medical Center Inc |
Inhibitoren der dipeptidyl-aminopeptidase vom typ-iv
|
|
US6825169B1
(en)
|
1991-10-22 |
2004-11-30 |
Trustees Of Tufts College |
Inhibitors of dipeptidyl-aminopeptidase type IV
|
|
JP3078322B2
(ja)
|
1991-12-12 |
2000-08-21 |
協和醗酵工業株式会社 |
チエノイミダゾピリドン誘導体
|
|
DE4141788A1
(de)
|
1991-12-18 |
1993-06-24 |
Merck Patent Gmbh |
Imidazopyridine
|
|
DE4305602A1
(de)
|
1992-06-17 |
1993-12-23 |
Merck Patent Gmbh |
Imidazopyridine
|
|
IL106998A0
(en)
|
1992-09-17 |
1993-12-28 |
Univ Florida |
Brain-enhanced delivery of neuroactive peptides by sequential metabolism
|
|
US5811281A
(en)
|
1993-07-12 |
1998-09-22 |
Cornell Research Foundation, Inc. |
Immortalized intestinal epithelial cell lines
|
|
IL111785A0
(en)
|
1993-12-03 |
1995-01-24 |
Ferring Bv |
Dp-iv inhibitors and pharmaceutical compositions containing them
|
|
DE4341453A1
(de)
|
1993-12-06 |
1995-06-08 |
Merck Patent Gmbh |
Imidazopyridine
|
|
KR100233703B1
(ko)
|
1994-03-08 |
1999-12-01 |
오츠까 요시미쯔 |
포스폰산 디에스테르 유도체
|
|
US5580979A
(en)
|
1994-03-15 |
1996-12-03 |
Trustees Of Tufts University |
Phosphotyrosine peptidomimetics for inhibiting SH2 domain interactions
|
|
US5543396A
(en)
|
1994-04-28 |
1996-08-06 |
Georgia Tech Research Corp. |
Proline phosphonate derivatives
|
|
AU2790895A
(en)
|
1994-06-10 |
1996-01-05 |
Universitaire Instelling Antwerpen |
Purification of serine protease and synthetic inhibitors thereof
|
|
US5589437A
(en)
*
|
1994-06-13 |
1996-12-31 |
Vichnevetskaia; Klara D. |
Method of using 5-hydroxybenzimidazole compounds for reducing transpiration in plants
|
|
US5601986A
(en)
|
1994-07-14 |
1997-02-11 |
Amgen Inc. |
Assays and devices for the detection of extrahepatic biliary atresia
|
|
DE4432860A1
(de)
|
1994-09-15 |
1996-03-21 |
Merck Patent Gmbh |
Imidazopyridine
|
|
US5512549A
(en)
|
1994-10-18 |
1996-04-30 |
Eli Lilly And Company |
Glucagon-like insulinotropic peptide analogs, compositions, and methods of use
|
|
US6362002B1
(en)
*
|
1995-03-17 |
2002-03-26 |
President And Fellows Of Harvard College |
Characterization of individual polymer molecules based on monomer-interface interactions
|
|
US5614379A
(en)
|
1995-04-26 |
1997-03-25 |
Eli Lilly And Company |
Process for preparing anti-obesity protein
|
|
US6265551B1
(en)
|
1995-06-01 |
2001-07-24 |
Dana-Farber Cancer Institute, Inc. |
Form of dipeptidylpeptidase IV (CD26) found in human serum, antibodies thereto, and uses thereof
|
|
US6325989B1
(en)
|
1995-06-01 |
2001-12-04 |
Dana-Farber Cancer Institute, Inc. |
Form of dipeptidylpeptidase IV (CD26) found in human serum
|
|
JPH0928376A
(ja)
|
1995-07-21 |
1997-02-04 |
Ajinomoto Co Inc |
新規ジペプチジルペプチダーゼｉｖとその製造方法
|
|
DE122010000020I1
(de)
|
1996-04-25 |
2010-07-08 |
Prosidion Ltd |
Verfahren zur Senkung des Blutglukosespiegels in Säugern
|
|
US20020006899A1
(en)
|
1998-10-06 |
2002-01-17 |
Pospisilik Andrew J. |
Use of dipeptidyl peptidase IV effectors for lowering blood pressure in mammals
|
|
US5965532A
(en)
|
1996-06-28 |
1999-10-12 |
Trustees Of Tufts College |
Multivalent compounds for crosslinking receptors and uses thereof
|
|
US5885997A
(en)
|
1996-07-01 |
1999-03-23 |
Dr. Reddy's Research Foundation |
Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
|
|
US5985884A
(en)
|
1996-07-01 |
1999-11-16 |
Dr. Reddy's Research Foundation |
Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
|
|
US7235627B2
(en)
|
1996-08-30 |
2007-06-26 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
|
US6006753A
(en)
|
1996-08-30 |
1999-12-28 |
Eli Lilly And Company |
Use of GLP-1 or analogs to abolish catabolic changes after surgery
|
|
US6458924B2
(en)
|
1996-08-30 |
2002-10-01 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
|
UA65549C2
(uk)
|
1996-11-05 |
2004-04-15 |
Елі Ліллі Енд Компані |
Спосіб регулювання ожиріння шляхом периферійного введення аналогів та похідних glp-1 (варіанти) та фармацевтична композиція
|
|
US6011155A
(en)
|
1996-11-07 |
2000-01-04 |
Novartis Ag |
N-(substituted glycyl)-2-cyanopyrrolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
|
|
GB9702701D0
(en)
|
1997-02-01 |
1997-04-02 |
Univ Newcastle Ventures Ltd |
Quinazolinone compounds
|
|
US6100234A
(en)
|
1997-05-07 |
2000-08-08 |
Tufts University |
Treatment of HIV
|
|
AU7381098A
(en)
|
1997-05-16 |
1998-12-08 |
Novo Nordisk Biotech, Inc. |
Polypeptides having prolyl pipeptidyl aminopeptidase activity and nucleic acids encoding same
|
|
EP0897012A1
(en)
|
1997-07-05 |
1999-02-17 |
Societe Des Produits Nestle S.A. |
Cloning of the prolyl-dipeptidyl-peptidase from aspergillus oryzae
|
|
US6235493B1
(en)
|
1997-08-06 |
2001-05-22 |
The Regents Of The University Of California |
Amino acid substituted-cresyl violet, synthetic fluorogenic substrates for the analysis of agents in individual in vivo cells or tissue
|
|
AU743996B2
(en)
|
1997-09-29 |
2002-02-14 |
Point Therapeutics, Inc. |
Stimulation of hematopoietic cells in vitro
|
|
US6485955B1
(en)
|
1997-10-06 |
2002-11-26 |
The Trustees Of Tufts University |
Quiescent cell dipeptidyl peptidase: a novel cytoplasmic serine protease
|
|
US6342611B1
(en)
|
1997-10-10 |
2002-01-29 |
Cytovia, Inc. |
Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for capsases and other enzymes and the use thereof
|
|
DE69833784T2
(de)
|
1997-12-16 |
2006-10-19 |
Novozymes A/S |
Polypeptide mit aminopeptidase-aktivität und für diese codierende nukleinsäuren
|
|
US6380357B2
(en)
|
1997-12-16 |
2002-04-30 |
Eli Lilly And Company |
Glucagon-like peptide-1 crystals
|
|
CA2819705C
(en)
|
1998-02-02 |
2014-07-08 |
Trustees Of Tufts College |
Method of regulating glucose metabolism, and reagents related thereto
|
|
US20020061839A1
(en)
|
1998-03-09 |
2002-05-23 |
Scharpe Simon Lodewijk |
Serine peptidase modulators
|
|
FR2777283B1
(fr)
|
1998-04-10 |
2000-11-24 |
Adir |
Nouveaux composes peptidiques analogues du glucagon-peptide- 1 (7-37), leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
IL139247A0
(en)
|
1998-05-04 |
2001-11-25 |
Point Therapeutics Inc |
Hematopoietic stimulation
|
|
DE19823831A1
(de)
|
1998-05-28 |
1999-12-02 |
Probiodrug Ges Fuer Arzneim |
Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen
|
|
AU765370B2
(en)
|
1998-06-05 |
2003-09-18 |
Point Therapeutics, Inc. |
Cyclic boroproline compounds
|
|
DE19828114A1
(de)
|
1998-06-24 |
2000-01-27 |
Probiodrug Ges Fuer Arzneim |
Produgs instabiler Inhibitoren der Dipeptidyl Peptidase IV
|
|
DE19828113A1
(de)
|
1998-06-24 |
2000-01-05 |
Probiodrug Ges Fuer Arzneim |
Prodrugs von Inhibitoren der Dipeptidyl Peptidase IV
|
|
US6129911A
(en)
|
1998-07-10 |
2000-10-10 |
Rhode Island Hospital, A Lifespan Partner |
Liver stem cell
|
|
DE19834591A1
(de)
|
1998-07-31 |
2000-02-03 |
Probiodrug Ges Fuer Arzneim |
Verfahren zur Steigerung des Blutglukosespiegels in Säugern
|
|
US20030176357A1
(en)
|
1998-10-06 |
2003-09-18 |
Pospisilik Andrew J. |
Dipeptidyl peptidase IV inhibitors and their uses for lowering blood pressure levels
|
|
DE19847690A1
(de)
|
1998-10-15 |
2000-04-20 |
Brahms Diagnostica Gmbh |
Verfahren und Substanzen für die Diagnose und Therapie von Sepsis und sepsisähnlichen systemischen Infektionen
|
|
CO5150173A1
(es)
|
1998-12-10 |
2002-04-29 |
Novartis Ag |
Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv
|
|
GB9906715D0
(en)
|
1999-03-23 |
1999-05-19 |
Ferring Bv |
Compositions for promoting growth
|
|
US6548529B1
(en)
|
1999-04-05 |
2003-04-15 |
Bristol-Myers Squibb Company |
Heterocyclic containing biphenyl aP2 inhibitors and method
|
|
WO2000063209A1
(en)
|
1999-04-20 |
2000-10-26 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
|
US6613879B1
(en)
|
1999-05-14 |
2003-09-02 |
Boehringer Ingelheim Pharma Kg |
FAP-activated anti-tumour compounds
|
|
US6890904B1
(en)
|
1999-05-25 |
2005-05-10 |
Point Therapeutics, Inc. |
Anti-tumor agents
|
|
DE19926233C1
(de)
|
1999-06-10 |
2000-10-19 |
Probiodrug Ges Fuer Arzneim |
Verfahren zur Herstellung von Thiazolidin
|
|
US6660716B1
(en)
|
1999-06-21 |
2003-12-09 |
Eli Lilly And Company |
Method for treating non-insulin dependent diabetes using thiazolidinediones with glucagon-like peptide-1 and agonists thereof
|
|
US6107317A
(en)
|
1999-06-24 |
2000-08-22 |
Novartis Ag |
N-(substituted glycyl)-thiazolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
|
|
US6110949A
(en)
|
1999-06-24 |
2000-08-29 |
Novartis Ag |
N-(substituted glycyl)-4-cyanothiazolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
|
|
US6172081B1
(en)
|
1999-06-24 |
2001-01-09 |
Novartis Ag |
Tetrahydroisoquinoline 3-carboxamide derivatives
|
|
US6528486B1
(en)
|
1999-07-12 |
2003-03-04 |
Zealand Pharma A/S |
Peptide agonists of GLP-1 activity
|
|
US6617340B1
(en)
|
1999-07-29 |
2003-09-09 |
Novartis Ag |
N-(substituted glycyl)-pyrrolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
|
|
DE19940130A1
(de)
|
1999-08-24 |
2001-03-01 |
Probiodrug Ges Fuer Arzneim |
Neue Effektoren der Dipeptidyl Peptidase IV zur topischen Anwendung
|
|
ES2269178T3
(es)
|
1999-09-10 |
2007-04-01 |
The University Of Sydney |
Dipeptidil peptidasas.
|
|
US6414002B1
(en)
|
1999-09-22 |
2002-07-02 |
Bristol-Myers Squibb Company |
Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
|
|
US6251391B1
(en)
|
1999-10-01 |
2001-06-26 |
Klaire Laboratories, Inc. |
Compositions containing dipepitidyl peptidase IV and tyrosinase or phenylalaninase for reducing opioid-related symptons
|
|
US6261794B1
(en)
|
1999-10-14 |
2001-07-17 |
Saint Louis University |
Methods for identifying inhibitors of methionine aminopeptidases
|
|
AU1916401A
(en)
|
1999-11-12 |
2001-06-06 |
Guilford Pharmaceuticals Inc. |
Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors
|
|
US20040152745A1
(en)
|
1999-11-12 |
2004-08-05 |
Guilford Pharmaceuticals, Inc. |
Dipeptidyl peptidase IV inhibitors and methods of making and using dipeptidyl peptidase IV inhibitors
|
|
GB9928330D0
(en)
|
1999-11-30 |
2000-01-26 |
Ferring Bv |
Novel antidiabetic agents
|
|
US6380398B2
(en)
|
2000-01-04 |
2002-04-30 |
Novo Nordisk A/S |
Therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV
|
|
DE122008000018I1
(de)
|
2000-01-21 |
2008-08-14 |
Novartis Pharma Ag |
Zusammensetzungen bestehend aus Dipeptidylpeptidase-IV Inhibitoren und Antidiabetica
|
|
US6569901B2
(en)
|
2000-01-28 |
2003-05-27 |
Novo Nordisk A/S |
Alkynyl-substituted propionic acid derivatives, their preparation and use
|
|
US7064145B2
(en)
|
2000-02-25 |
2006-06-20 |
Novo Nordisk A/S |
Inhibition of beta cell degeneration
|
|
US6395767B2
(en)
|
2000-03-10 |
2002-05-28 |
Bristol-Myers Squibb Company |
Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
|
|
US6608038B2
(en)
|
2000-03-15 |
2003-08-19 |
Novartis Ag |
Methods and compositions for treatment of diabetes and related conditions via gene therapy
|
|
US6555519B2
(en)
|
2000-03-30 |
2003-04-29 |
Bristol-Myers Squibb Company |
O-glucosylated benzamide SGLT2 inhibitors and method
|
|
ATE419036T1
(de)
|
2000-03-31 |
2009-01-15 |
Prosidion Ltd |
Verbesserung der aktivität der inselzellen bei diabetes mellitus und dessen prävention
|
|
US6573096B1
(en)
|
2000-04-01 |
2003-06-03 |
The Research Foundation At State University Of New York |
Compositions and methods for inhibition of cancer invasion and angiogenesis
|
|
US6545170B2
(en)
|
2000-04-13 |
2003-04-08 |
Pharmacia Corporation |
2-amino-5, 6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
|
|
GB0010183D0
(en)
|
2000-04-26 |
2000-06-14 |
Ferring Bv |
Inhibitors of dipeptidyl peptidase IV
|
|
GB0010188D0
(en)
|
2000-04-26 |
2000-06-14 |
Ferring Bv |
Inhibitors of dipeptidyl peptidase IV
|
|
DE10025464A1
(de)
|
2000-05-23 |
2001-12-06 |
Inst Medizintechnologie Magdeb |
Kombinierte Verwendung von Enzyminhibitoren zur Therapie von Autoimmunerkrankungen, bei Transplantationen und Tumorerkrankungen sowie Kombinationen von Enzyminhibitoren umfassende pharmazeutische Zubereitungen
|
|
WO2001092493A2
(en)
|
2000-05-26 |
2001-12-06 |
Millennium Pharmaceuticals, Inc. |
21956 and 25856, human aminopeptidases and uses thereof
|
|
US6783757B2
(en)
|
2000-06-01 |
2004-08-31 |
Kirkman Group, Inc. |
Composition and method for increasing exorphin catabolism to treat autism
|
|
US6432969B1
(en)
|
2000-06-13 |
2002-08-13 |
Novartis Ag |
N-(substituted glycyl)-2 cyanopyrrolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
|
|
TW583185B
(en)
|
2000-06-13 |
2004-04-11 |
Novartis Ag |
N-(substituted glycyl)-2-cyanopyrrolidines and pharmaceutical composition for inhibiting dipeptidyl peptidase-IV (DPP-IV) or for the prevention or treatment of diseases or conditions associated with elevated levels of DPP-IV comprising the same
|
|
US6627636B2
(en)
|
2000-06-15 |
2003-09-30 |
Bristol-Myers Squibb Company |
HMG-CoA reductase inhibitors and method
|
|
US6620821B2
(en)
|
2000-06-15 |
2003-09-16 |
Bristol-Myers Squibb Company |
HMG-CoA reductase inhibitors and method
|
|
US7078397B2
(en)
|
2000-06-19 |
2006-07-18 |
Smithkline Beecham Corporation |
Combinations of dipeptidyl peptidase IV inhibitors and other antidiabetic agents for the treatment of diabetes mellitus
|
|
GB0014969D0
(en)
|
2000-06-19 |
2000-08-09 |
Smithkline Beecham Plc |
Novel method of treatment
|
|
JP2004502690A
(ja)
|
2000-07-04 |
2004-01-29 |
ノボ ノルディスク アクティーゼルスカブ |
酵素ｄｐｐ−ｉｖのインヒビターである複素環式化合物
|
|
EP1305293A1
(en)
|
2000-08-01 |
2003-05-02 |
Pharmacia Corporation |
Hexahydro-7-imino-1h-azepin-2-yl-hexanoic acid derivatives as inhibitors of inducible nitric oxide synthase
|
|
AU2001277032A1
(en)
|
2000-08-04 |
2002-02-18 |
Warner Lambert Company |
2-(4-pyridyl)amino-6-dialkoxyphenyl-pyrido(2,3-d)pyrimidin-7 ones
|
|
NZ524618A
(en)
|
2000-08-10 |
2004-08-27 |
Mitsubishi Pharma Corp |
Proline derivatives and use thereof as drugs
|
|
US20020165237A1
(en)
|
2000-08-11 |
2002-11-07 |
Fryburg David Albert |
Treatment of the insulin resistance syndrome
|
|
US20020037829A1
(en)
|
2000-08-23 |
2002-03-28 |
Aronson Peter S. |
Use of DPPIV inhibitors as diuretic and anti-hypertensive agents
|
|
JP5433840B2
(ja)
|
2000-09-09 |
2014-03-05 |
ザ・リサーチ・ファウンデーション・フォー・ザ・ステイト・ユニヴァーシティ・オブ・ニューヨーク |
転移癌細胞を単離するための方法および組成物、ならびに癌の転移能の測定におけるその使用
|
|
CN1280269C
(zh)
|
2000-10-06 |
2006-10-18 |
田边制药株式会社 |
脂肪族含氮五员环化合物
|
|
WO2002031134A2
(en)
|
2000-10-12 |
2002-04-18 |
Ferring Bv |
Novel serine protease genes related to dppiv
|
|
RU2286149C2
(ru)
|
2000-10-27 |
2006-10-27 |
Пробиодруг Аг |
Способ для лечения неврологических и нейропсихологических нарушений
|
|
AUPR107800A0
(en)
|
2000-10-27 |
2000-11-23 |
University Of Sydney, The |
Peptide and nucleic acid molecule ii
|
|
MXPA03003870A
(es)
|
2000-10-30 |
2004-08-12 |
Johnson & Johnson |
Terapia de combinacion que comprende agentes antidiabeticos y anticonvulsionantes.
|
|
US6586198B2
(en)
|
2000-10-31 |
2003-07-01 |
Vanderbilt University |
Method of identifying susceptibility to angiotensin converting enzyme inhibto- and vasopeptidase-inhibitor-associated angioedema
|
|
US6864363B2
(en)
|
2000-11-08 |
2005-03-08 |
University Of Georgia Research Foundation, Inc. |
Dipeptidylpeptidases and methods of use
|
|
TWI243162B
(en)
|
2000-11-10 |
2005-11-11 |
Taisho Pharmaceutical Co Ltd |
Cyanopyrrolidine derivatives
|
|
US20020155565A1
(en)
|
2000-11-10 |
2002-10-24 |
Pilar Garin-Chesa |
FAP-activated anti-tumor compounds
|
|
US20030055052A1
(en)
|
2000-11-10 |
2003-03-20 |
Stefan Peters |
FAP-activated anti-tumor compounds
|
|
US20030203946A1
(en)
|
2000-11-17 |
2003-10-30 |
Carsten Behrens |
Glucagon antagonists/inverse agonists
|
|
EP1343763A1
(en)
|
2000-11-20 |
2003-09-17 |
Bristol-Myers Squibb Company |
Pyrodone derivatives as ap2 inhibitors
|
|
EP1343505A1
(en)
|
2000-12-11 |
2003-09-17 |
Tularik Inc. |
Cxcr3 antagonists
|
|
US20040180925A1
(en)
|
2000-12-27 |
2004-09-16 |
Kenji Matsuno |
Dipeptidylpeptidase-IV inhibitor
|
|
DE10100053A1
(de)
|
2001-01-02 |
2002-08-22 |
Keyneurotek Ag I G |
Verwendung von Enzyminhibitoren der Dipeptidylpeptidase IV sowie der Aminopeptidase N und pharmazeutischen Zubereitungen daraus zur Prävention und/oder Therapie Ischämie-bedingter akuter und chronischer neurodegenerativer Prozesse und Erkrankungen
|
|
EP1349576B1
(de)
|
2001-01-02 |
2011-11-23 |
IMTM GmbH |
Kombinierte verwendung von enzyminhibitoren zur therapie und prävention allergischer reaktionen vom typ i nach gell und coombs und zur therapie und prävention dermatologischer erkrankungen mit follikulären und epidermalen hyperkeratosen und einer verstärkten keratinozytenproliferation
|
|
GB0101760D0
(en)
|
2001-01-23 |
2001-03-07 |
Glaxo Group Ltd |
Novel protein
|
|
PE20021002A1
(es)
|
2001-02-02 |
2002-12-06 |
Takeda Chemical Industries Ltd |
Compuestos heterociclicos condensados
|
|
TWI255817B
(en)
|
2001-02-14 |
2006-06-01 |
Kissei Pharmaceutical |
Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof
|
|
EP1757606B1
(de)
|
2001-02-24 |
2009-05-06 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Xanthinderivate Verwendung als Arzneimittel sowie deren Verfahren zur deren Herstellung
|
|
US6337069B1
(en)
|
2001-02-28 |
2002-01-08 |
B.M.R.A. Corporation B.V. |
Method of treating rhinitis or sinusitis by intranasally administering a peptidase
|
|
AU2002251067B2
(en)
|
2001-03-19 |
2005-05-26 |
Novartis Ag |
Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative
|
|
AU2002306823B2
(en)
|
2001-03-27 |
2006-05-11 |
Merck & Co., Inc. |
Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
|
FR2822826B1
(fr)
|
2001-03-28 |
2003-05-09 |
Servier Lab |
Nouveaux derives sulfonyles d'alpha-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
DE10115921A1
(de)
|
2001-03-30 |
2002-10-02 |
Boehringer Ingelheim Pharma |
Verfahren zur Herstellung von 4,6-Diaminopyrimido[5,4-d]pyrimidinen
|
|
US6890905B2
(en)
|
2001-04-02 |
2005-05-10 |
Prosidion Limited |
Methods for improving islet signaling in diabetes mellitus and for its prevention
|
|
GB0109146D0
(en)
|
2001-04-11 |
2001-05-30 |
Ferring Bv |
Treatment of type 2 diabetes
|
|
US6573287B2
(en)
|
2001-04-12 |
2003-06-03 |
Bristo-Myers Squibb Company |
2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase IV and method
|
|
PE20021080A1
(es)
|
2001-04-12 |
2003-02-12 |
Boehringer Ingelheim Int |
Un anticuerpo especifico fapo bibh1 en el tratamiento del cancer
|
|
FR2824825B1
(fr)
|
2001-05-15 |
2005-05-06 |
Servier Lab |
Nouveaux derives d'alpha-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
US20030060494A1
(en)
|
2001-05-18 |
2003-03-27 |
Nobuyuki Yasuda |
Pharmaceutical use of N-carbamoylazole derivatives
|
|
US7105556B2
(en)
|
2001-05-30 |
2006-09-12 |
Bristol-Myers Squibb Company |
Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method
|
|
US6794379B2
(en)
|
2001-06-06 |
2004-09-21 |
Tularik Inc. |
CXCR3 antagonists
|
|
AU2002344820B2
(en)
|
2001-06-20 |
2006-12-14 |
Merck & Co., Inc. |
Dipeptidyl peptidase inhibitors for the treatment of diabetes
|
|
CA2450475A1
(en)
|
2001-06-20 |
2003-01-03 |
Linda Brockunier |
Dipeptidyl peptidase inhibitors for the treatment of diabetes
|
|
RU2003105463A
(ru)
|
2001-06-27 |
2004-11-27 |
Пробиодруг Аг (De) |
Пептидные структуры, пригодные для конкурентного модулирования катализа, осуществляемого дипептидилпептидазой iv
|
|
US7183290B2
(en)
|
2001-06-27 |
2007-02-27 |
Smithkline Beecham Corporation |
Fluoropyrrolidines as dipeptidyl peptidase inhibitors
|
|
US7368421B2
(en)
|
2001-06-27 |
2008-05-06 |
Probiodrug Ag |
Use of dipeptidyl peptidase IV inhibitors in the treatment of multiple sclerosis
|
|
US20030135023A1
(en)
|
2001-06-27 |
2003-07-17 |
Hans-Ulrich Demuth |
Peptide structures useful for competitive modulation of dipeptidyl peptidase IV catalysis
|
|
JP4300108B2
(ja)
|
2001-06-27 |
2009-07-22 |
スミスクライン ビーチャム コーポレーション |
ジペプチジルペプチダーゼ阻害剤としてのピロリジン類
|
|
US20030130199A1
(en)
|
2001-06-27 |
2003-07-10 |
Von Hoersten Stephan |
Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents
|
|
JP2004521149A
(ja)
|
2001-06-27 |
2004-07-15 |
プロバイオドラッグ アーゲー |
新規なジペプチジルぺプチダ−ゼｉｖ阻害剤およびそれらの抗癌剤としての使用
|
|
DE10150203A1
(de)
|
2001-10-12 |
2003-04-17 |
Probiodrug Ag |
Peptidylketone als Inhibitoren der DPIV
|
|
DE10154689A1
(de)
|
2001-11-09 |
2003-05-22 |
Probiodrug Ag |
Substituierte Aminoketonverbindungen
|
|
ES2296979T3
(es)
|
2001-06-27 |
2008-05-01 |
Smithkline Beecham Corporation |
Fluoropirrolidinas como inhibidores de dipeptidil peptidasa.
|
|
US6869947B2
(en)
|
2001-07-03 |
2005-03-22 |
Novo Nordisk A/S |
Heterocyclic compounds that are inhibitors of the enzyme DPP-IV
|
|
UA74912C2
(en)
|
2001-07-06 |
2006-02-15 |
Merck & Co Inc |
Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes
|
|
WO2003007888A2
(en)
|
2001-07-20 |
2003-01-30 |
Adipogenix, Inc. |
Fat accumulation-modulating compounds
|
|
JP2005508891A
(ja)
|
2001-08-13 |
2005-04-07 |
プロバイオドラッグ アーゲー |
レグマインの不可逆性システインプロテアーゼ阻害剤
|
|
DE10143840A1
(de)
|
2001-09-06 |
2003-03-27 |
Probiodrug Ag |
Neue Inhibitoren der Dipeptidylpeptidase I
|
|
US6844316B2
(en)
|
2001-09-06 |
2005-01-18 |
Probiodrug Ag |
Inhibitors of dipeptidyl peptidase I
|
|
US6673829B2
(en)
|
2001-09-14 |
2004-01-06 |
Novo Nordisk A/S |
Aminoazetidine,-pyrrolidine and -piperidine derivatives
|
|
US20030186963A1
(en)
|
2001-09-14 |
2003-10-02 |
Dorwald Florencio Zaragoza |
Substituted piperidines
|
|
TWI246510B
(en)
|
2001-09-14 |
2006-01-01 |
Mitsubishi Pharma Corp |
Thiazolidine derivatives and pharmaceutical uses thereof
|
|
JP2005509603A
(ja)
|
2001-09-19 |
2005-04-14 |
ノボ ノルディスク アクティーゼルスカブ |
Ｄｐｐ−ｉｖ酵素の阻害剤であるヘテロ環化合物
|
|
HRP20040280B1
(hr)
|
2001-09-21 |
2013-09-30 |
Bristol-Myers Squibb Company A Delaware (Usa) Corporation |
SPOJEVI KOJI SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa
|
|
US7019010B2
(en)
|
2001-09-27 |
2006-03-28 |
Novertis Ag |
Combinations
|
|
HRP20040311A2
(en)
|
2001-10-01 |
2005-02-28 |
Bristol-Myers Squibb Company Cerep SA |
Spiro-hydantoin compounds useful as anti-inflammatory agents
|
|
WO2003030946A1
(en)
|
2001-10-09 |
2003-04-17 |
Novartis Ag |
Regulation of insulin production
|
|
US7064135B2
(en)
|
2001-10-12 |
2006-06-20 |
Novo Nordisk Inc. |
Substituted piperidines
|
|
GB0125445D0
(en)
|
2001-10-23 |
2001-12-12 |
Ferring Bv |
Protease Inhibitors
|
|
US6861440B2
(en)
|
2001-10-26 |
2005-03-01 |
Hoffmann-La Roche Inc. |
DPP IV inhibitors
|
|
EP1442028A4
(en)
|
2001-11-06 |
2009-11-04 |
Bristol Myers Squibb Co |
SUBSTITUTED ACID DERIVATIVES, WHICH APPRECIATE AS ANTIDIBILICS AND AGENTS AGAINST OBESITAS, AND METHODS
|
|
US20030125304A1
(en)
|
2001-11-09 |
2003-07-03 |
Hans-Ulrich Demuth |
Substituted amino ketone compounds
|
|
JP2005511636A
(ja)
|
2001-11-26 |
2005-04-28 |
トラスティーズ オブ タフツ カレッジ |
自己免疫疾患の治療方法及びそれに関する試薬
|
|
JP4771661B2
(ja)
|
2001-11-26 |
2011-09-14 |
トラスティーズ オブ タフツ カレッジ |
Ｐｏｓｔ−プロリン開裂酵素の擬ペプチド性阻害剤
|
|
WO2003048081A2
(en)
|
2001-12-04 |
2003-06-12 |
Bristol-Myers Squibb Company |
Glycinamides as factor xa inhibitors
|
|
AU2002351732A1
(en)
|
2001-12-14 |
2003-06-30 |
Novo Nordisk A/S |
Compositions decreasing activity of hormone-sensitive lipase
|
|
JP2005518391A
(ja)
|
2001-12-21 |
2005-06-23 |
ノボ ノルディスク アクティーゼルスカブ |
Ｇｋ活性化剤としてのアミド誘導体
|
|
TW200301698A
(en)
|
2001-12-21 |
2003-07-16 |
Bristol Myers Squibb Co |
Acridone inhibitors of IMPDH enzyme
|
|
US6727261B2
(en)
|
2001-12-27 |
2004-04-27 |
Hoffman-La Roche Inc. |
Pyrido[2,1-A]Isoquinoline derivatives
|
|
DE60217918T2
(de)
|
2001-12-29 |
2007-11-15 |
Novo Nordisk A/S |
Kombinierte verwendung einer glp-1-verbindung und eines aldose reduktase inhibitors
|
|
ATE409466T1
(de)
|
2002-01-11 |
2008-10-15 |
Novo Nordisk As |
Verfahren und zusammensetzung zur behandlung von diabetes, hypertonie, chronischer herzinsuffizienz und mit flüssigkeitsretention einhergehenden zuständen
|
|
AU2003218969A1
(en)
|
2002-02-01 |
2003-09-02 |
Probiodrug Ag |
Modulation of t lymphocytes using dp iv inhibitors
|
|
US7101898B2
(en)
|
2002-02-01 |
2006-09-05 |
Novo Nordisk A/S |
Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes
|
|
CN1308311C
(zh)
|
2002-02-13 |
2007-04-04 |
霍夫曼-拉罗奇有限公司 |
新型吡啶－和喹啉－衍生物
|
|
ATE472536T1
(de)
|
2002-02-13 |
2010-07-15 |
Hoffmann La Roche |
Pyridin- und pyrimidin-derivate
|
|
DE60301491T2
(de)
|
2002-02-27 |
2006-05-18 |
Pfizer Products Inc., Groton |
Acc-hemmer
|
|
IL163629A0
(en)
|
2002-02-28 |
2005-12-18 |
Prosidion Ltd |
Glutaminyl derivatives and pharmaceutical compositions containing the same
|
|
US20080070864A1
(en)
|
2002-03-07 |
2008-03-20 |
X-Ceptor Therapeutics, Inc. |
Quinazolinone Modulators Of Nuclear Receptors
|
|
US6947847B2
(en)
|
2002-03-08 |
2005-09-20 |
Wisconsin Alumni Research Foundation |
Method to design therapeutically important compounds
|
|
US20030232761A1
(en)
|
2002-03-28 |
2003-12-18 |
Hinke Simon A. |
Novel analogues of glucose-dependent insulinotropic polypeptide
|
|
US20040106802A1
(en)
|
2002-04-08 |
2004-06-03 |
Torrent Pharmaceuticals Ltd. |
Novel compounds and therapeutic uses thereof
|
|
BR0308816A
(pt)
|
2002-04-08 |
2005-03-22 |
Torrent Pharmaceuticals Ltd |
Tiazolidina-4-carbonitrilas e análogos e seus usos como inibidores da dipeptil-peptidas
|
|
WO2003092605A2
(en)
|
2002-04-30 |
2003-11-13 |
Trustees Of Tufts College |
Protease inhibitors
|
|
TW200307667A
(en)
|
2002-05-06 |
2003-12-16 |
Bristol Myers Squibb Co |
Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors
|
|
US7057046B2
(en)
|
2002-05-20 |
2006-06-06 |
Bristol-Myers Squibb Company |
Lactam glycogen phosphorylase inhibitors and method of use
|
|
CA2486966A1
(en)
|
2002-05-23 |
2003-12-04 |
Chiron Corporation |
Substituted quinazolinone compounds
|
|
GB0212412D0
(en)
|
2002-05-29 |
2002-07-10 |
Novartis Ag |
Combination of organic compounds
|
|
AU2003233010A1
(en)
|
2002-06-04 |
2003-12-19 |
Pfizer Products Inc. |
Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof
|
|
US6710040B1
(en)
|
2002-06-04 |
2004-03-23 |
Pfizer Inc. |
Fluorinated cyclic amides as dipeptidyl peptidase IV inhibitors
|
|
US20060100199A1
(en)
|
2002-06-06 |
2006-05-11 |
Seiji Yoshikawa |
Novel condensed imidazole derivatives
|
|
WO2003106628A2
(en)
|
2002-06-17 |
2003-12-24 |
Bristol-Myers Squibb Company |
Benzodiazepine inhibitors of mitochondial f1f0 atp hydrolase and methods of inhibiting f1f0 atp hydrolase
|
|
US20040054171A1
(en)
|
2002-07-04 |
2004-03-18 |
Jensen Anette Frost |
Polymorphic forms of a 4H-thieno[3,2-E]-1,2,4-thiadiazine 1,1-dioxide derivative
|
|
EP1528931B1
(en)
|
2002-08-09 |
2008-05-07 |
Prosidion Ltd. |
Dipeptidyl peptidase iv inhibitors for decreasing the rate of chronic weight gain
|
|
US7407955B2
(en)
|
2002-08-21 |
2008-08-05 |
Boehringer Ingelheim Pharma Gmbh & Co., Kg |
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
|
|
DE10238470A1
(de)
|
2002-08-22 |
2004-03-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
|
US7569574B2
(en)
|
2002-08-22 |
2009-08-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Purine derivatives, the preparation thereof and their use as pharmaceutical compositions
|
|
US7495005B2
(en)
|
2002-08-22 |
2009-02-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Xanthine derivatives, their preparation and their use in pharmaceutical compositions
|
|
US20040058876A1
(en)
|
2002-09-18 |
2004-03-25 |
Torsten Hoffmann |
Secondary binding site of dipeptidyl peptidase IV (DP IV)
|
|
AU2003293311A1
(en)
|
2002-09-18 |
2004-04-23 |
Prosidion Ltd. |
Secondary binding site of dipeptidyl peptidase iv (dp iv)
|
|
US7262207B2
(en)
|
2002-09-19 |
2007-08-28 |
Abbott Laboratories |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
|
|
US6869966B2
(en)
|
2002-09-30 |
2005-03-22 |
Banyu Pharmaceutical Co., Ltd. |
N-substituted-2-oxodihydropyridine derivatives
|
|
NZ538897A
(en)
|
2002-10-18 |
2007-02-23 |
Merck & Co Inc |
Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
|
EP1553947A4
(en)
|
2002-10-21 |
2006-11-29 |
Bristol Myers Squibb Co |
QUINAZOLINONES AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS
|
|
AU2003282983A1
(en)
|
2002-10-23 |
2004-05-13 |
Bristol-Myers Squibb Company |
Glycinenitrile-based inhibitors of dipeptidyl peptidase iv and methods
|
|
US7482337B2
(en)
|
2002-11-08 |
2009-01-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
|
|
AU2003274601A1
(en)
|
2002-11-18 |
2004-06-15 |
Pfizer Products Inc. |
Dipeptidyl peptidase iv inhibiting fluorinated cyclic amides
|
|
DE10254304A1
(de)
|
2002-11-21 |
2004-06-03 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
|
UY28103A1
(es)
|
2002-12-03 |
2004-06-30 |
Boehringer Ingelheim Pharma |
Nuevas imidazo-piridinonas sustituidas, su preparación y su empleo como medicacmentos
|
|
US7109192B2
(en)
|
2002-12-03 |
2006-09-19 |
Boehringer Ingelheim Pharma Gmbh & Co Kg |
Substituted imidazo-pyridinones and imidazo-pyridazinones, the preparation thereof and their use as pharmaceutical compositions
|
|
US7524847B2
(en)
*
|
2002-12-04 |
2009-04-28 |
Eisai R&D Management Co., Ltd. |
Fused 1,3-dihydro-imidazole ring compounds
|
|
US7209978B2
(en)
|
2002-12-13 |
2007-04-24 |
Cisco Technology, Inc. |
Arrangement in a router of a mobile network for optimizing use of messages carrying reverse routing headers
|
|
US7148246B2
(en)
|
2003-02-27 |
2006-12-12 |
Sanofi-Aventis Deutschland Gmbh |
Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals
|
|
US20050014732A1
(en)
|
2003-03-14 |
2005-01-20 |
Pharmacia Corporation |
Combination of an aldosterone receptor antagonist and an anti-diabetic agent
|
|
JP4887139B2
(ja)
|
2003-03-25 |
2012-02-29 |
武田薬品工業株式会社 |
ジペプチジルペプチダーゼインヒビター
|
|
EP1622870A2
(en)
|
2003-05-05 |
2006-02-08 |
Prosidion Ltd. |
Glutaminyl based dp iv-inhibitors
|
|
DE602004026712D1
(de)
|
2003-05-05 |
2010-06-02 |
Probiodrug Ag |
Medizinische verwendung von hemmern von glutaminyl und glutamatcyclasen
|
|
EP1625122A1
(en)
|
2003-05-14 |
2006-02-15 |
Takeda San Diego, Inc. |
Dipeptidyl peptidase inhibitors
|
|
US7566707B2
(en)
|
2003-06-18 |
2009-07-28 |
Boehringer Ingelheim International Gmbh |
Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions
|
|
WO2005000848A1
(en)
|
2003-06-20 |
2005-01-06 |
F. Hoffmann-La Roche Ag |
Pyrido` 2, 1-a - isoquinoline derivatives as dpp-iv inhibitors
|
|
KR100744893B1
(ko)
|
2003-06-20 |
2007-08-01 |
에프. 호프만-라 로슈 아게 |
Ｄｐｐ-ｉｖ 저해제로서 헥사하이드로피리도아이소퀴놀린
|
|
JO2625B1
(en)
|
2003-06-24 |
2011-11-01 |
ميرك شارب اند دوم كوربوريشن |
Phosphoric acid salts of dipeptidyl betidase inhibitor 4
|
|
US6995183B2
(en)
|
2003-08-01 |
2006-02-07 |
Bristol Myers Squibb Company |
Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods
|
|
WO2005019168A2
(en)
|
2003-08-20 |
2005-03-03 |
Pfizer Products Inc. |
Fluorinated lysine derivatives as dipeptidyl peptidase iv inhibitors
|